STOCK BROKER REVIEW | INVESTING | UPCOMING IPO | ALGO TRADING | TECHNICAL ANALYSIS

Accretion Pharmaceuticals Limited IPO Basis Of allotments status

 

Get Real-Time Updates on stock market trends and news

Get updates on stock market, Stock related news, Algo Trading, learn profitable strategies.

Join WhatsApp Channel

Accretion Pharmaceuticals Limited IPO

May 14, 2025 - May 16, 2025 Closed

Accretion Pharmaceuticals Limited IPO Details

Issue Open

14 May 2025

Issue Close

16 May 2025

IPO Price

₹96 to ₹101 per equity share

Face Value

₹10 per equity share

IPO Size

₹29.75 Cr.

Listing At

NSE, SME

IPO Lot Size

1,200 shares

 

Accretion Pharmaceuticals Limited IPO Promoter Holdings:

Pre-Issue Share Holding

      100.00%

Post-Issue Share Holding

     73.48%


Accretion Pharmaceuticals Limited IPO Registrar Details:
MUFG INTIME INDIA PRIVATE LIMITED
Selenium, Tower B, Plot No 31 and 32, Financial District, Nanakramguda,
Serilingampally, Hyderabad, Telangana, 500032.
Tel:  +91 40 6716 2222/18003094001
E-mail: einward.ris@kfintech.com
Website:  www.in.mpms.mufg.com

 

Frequently Asked Question

Post-issue shareholding of the Accretion Pharmaceuticals Limited IPO promoter is 73.48%.
Opening date of Accretion Pharmaceuticals Limited IPO is May 14, 2025.
Accretion Pharmaceuticals Limited IPO Share price Shares will be listed at NSE SME.
You will receive on Accretion Pharmaceuticals Limited IPO shares in your Demat account on May 19, 2025, if allotted.
Pre-issue shareholding of the accrete pharmaceuticals private limited promoter is 100.00%.
IPO application is an online process by using UPI or ASBA as a payment method. ASBA IPO application is already available in the net banking of your respective bank account and the UPI application is offered by your Stockbroker, you can invest in Kenrik Industries Limited using any neatest method at your convenience.
An IPO “Initial Public Offering” is the process by which a private company offers that’s shares to the public for the first time to raise capital.
The meaning of "Accretion Pharmaceuticals Limited IPO" is the Grey Market Premium (GMP) for the initial public offering (IPO) of Accretion Pharmaceuticals Limited IPO on the current day.
Investors can check the status of their IPO application on the registrar's website by entering their application details or through their respective brokers.
Accretion Pharmaceuticals Limited IPO shares will get listed on May 21 2025.
The face value of Accretion Pharmaceuticals Limited IPO is ₹10 per share.
Key financial metrics, including revenue, profit margins, and other financial data, will be available in the company's prospectus and financial statements.
Lot size of the Accretion Pharmaceuticals Limited IPO is 1200 shares.
If you do not get the allotment of on Accretion Pharmaceuticals Limited IPO, your IPO application amount will be released or credited back to your bank account via which you applied for this IPO.
The price band for the Accretion Pharmaceuticals Limited IPO will be specified in the company's official prospectus.
Accretion Pharmaceuticals Limited IPO Products share price ₹96 to ₹101 per share.
Comments for Accretion Pharmaceuticals Limited IPO Basis Of allotments status

0 comments